Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized double-blind placebo-controlled study of Allocetra-OTS in severe or critical COVID-19 with ARDS
MOH_2021-08-18_010213Phase 2Completed
- Sponsor
- Anelixis Therapeutics
- Start
- Jul 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Placebo + standard of care with Allocetra-OTS + standard of care (2 arms). Started Jul 2021; status: completed.
02
Drugs
Allocetra
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2021-08-18_010213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-08-18_010213.